Pharma falls short in providing access to low- and middle-income countries
Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, a new analysis finds that overall
Read MoreAlthough more pharmaceutical companies are tailoring their business models to focus on low-income countries, a new analysis finds that overall
Read MoreThe medical communications (med comms) industry is critical in bridging the gap between new medical innovations, healthcare professionals (HCPs) and
Read MoreChina has approved 113 innovative drugs since its 14th five-year plan began in 2021, according to data shared at a
Read MoreMergers and acquisitions could make a comeback with Trump headed back to Washington. The 2024 presidential election and President-elect Donald
Read MoreThe rapid pace of technological advancement has outstripped the ability of traditional training programs to keep up, creating a significant
Read MoreSatellos Bioscience (TSX: MSCL, OTCQB: MSCLF) has appointed Stephanie Brown to its Board of Directors. Brown brings over 30 years
Read MoreThe pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could
Read MoreJubilant Pharmova, a midcap pharmaceutical company, saw a -5.27% decline in stock price on November 12, 2024, causing concern among
Read MoreAt the Outsourcing in Clinical Trials Conference in New England, experts shared insights on how the US clinical trial and
Read MoreEvolving industry demands are driving the need for greater flexibility and innovation in processing equipment for pharmaceutical manufacturing. Flexibility in
Read More